Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Apply
OTS167
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step